Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | NR5A2 | O00482 | 1/20 | 1.00 |
| ▸ | NR5A1 | Q13285 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.88 |
| ▸ | FABP3 | P05413 | 1/20 | 0.78 |
| ▸ | RECQL | P46063 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.66 |
| ▸ | PTAFR | P25105 | 1/20 | 0.66 |
| ▸ | HTR1D | P28221 | 1/20 | 0.66 |
| ▸ | HTR2C | P28335 | 1/20 | 0.66 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.66 |
| ▸ | DRD3 | P35462 | 1/20 | 0.66 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.66 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.63 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.63 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | GMNN | O75496 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimyristoylphosphatidylcholine SCHEMBL244839 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL10498112 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| Dimyristoylphosphatidylcholine SCHEMBL37475 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL234790 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL233046 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL22693933 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| Dimyristoylphosphatidylcholine SCHEMBL236969 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL231824 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL2036043 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 | |
| SCHEMBL24563 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2NR5A2NR5A1MAPTFABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19648 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144750-A1 | Dosing Regimens for Treatment of Glioblastoma | SIGNPATH PHARMA INC. (US) | 2026-05-28 | — | — | US | claimed |
| US-20260144759-A1 | Surface-modified plant-derived extracellular vesicles and targeted drug delivery system using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-05-28 | — | — | US | claimed |
| EP-4746913-A1 | LIPID NANOPARTICLES COMPRISING POLYMER-CONJUGATED LIPIDS AND USES THEREOF | Pfizer Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4746852-A1 | LIPID AGGREGATES FOR INTRAARTICULAR ADMINISTRATION | Universität Bern (CH) | 2026-05-27 | — | — | EP | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4746859-A2 | COMPOSITION AND METHOD FOR MAKING LIPID NANO-CARRIERS AND THE CORRESPONDING LIPID NANO-CARRIERS FOR BIOMEDICAL USE | Università degli Studi di Salerno (IT) | 2026-05-27 | — | — | EP | claimed |
| EP-4746923-A2 | DELIVERY SYSTEM COMPRISING LIPID OR POLYMERIC NANOPARTICLES COMPRISING THYROID HORMONES | FONDAZIONE RICCARDO TERZI E SILVIO ALBINI (IT) | 2026-05-27 | — | — | EP | claimed |
| US-12636252-B2 | Process of preparing mRNA-loaded lipid nano particles | TRANSLATE BIO, INC. (US) | 2026-05-26 | — | — | US | claimed |
| CN-117224502-B | Preparation method and application of bionic lipoprotein nano-disk | THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12636368-B2 | Ionizable lipids for nucleic acid delivery | GLOBAL LIFE SCIENCES SOLUTIONS CANADA ULC (CA) | 2026-05-26 | — | — | US | claimed |
| EP-0971699-A1 | METHOD FOR UTILIZING NEUTRAL LIPIDS TO MODIFY IN VIVO RELEASE FROM MULTIVESICULAR LIPOSOMES | SkyePharma Inc. (US) | 2000-01-19 | — | — | EP | claimed |
| US-6013619-A | APPLYING GAS POSITIVE END-EXPIRATORY PRESSURE WITH VENTILATOR INTO LUNG SECTION OF MAMMAL, INSTILLING LAVAGE COMPOSITION CONTAINING DILUTE SURFACTANT IN A PHARMACEUTICALLY ACCEPTABLE AQUEOUS MEDIUM INTO LUNG, REMOVING PULMONARY FLUID | THE SCRIPPS RESEARCH INSTITUTE (US) | 2000-01-11 | — | — | US | claimed |
| US-5997899-A | INCREASING THE NUMBER OF CARBONS IN THE CARBON CHAIN OF AT LEAST ONE LIPID IN THE LIPID COMPONENT OF THE LIPOSOME, WHEREIN THE CHEMICAL STRUCTURES OF THE TWO LIPIDS ARE OTHERWISE SUBSTANTIALLY SIMILAR. | SKYEPHARMA INC. (US) | 1999-12-07 | — | — | US | claimed |
| WO-1999056776-A2 | ADJUVANT COMPOSITION AND METHODS FOR ITS USE | CORIXA CORPORATION (US) | 1999-11-11 | — | — | WO | claimed |
| WO-1998050399-A1 | AMINOALKYL GLUCOSAMINE PHOSPHATE COMPOUNDS AND THEIR USE AS ADJUVANTS AND IMMUNOEFFECTORS | CORIXA CORPORATION (US) | 1998-11-12 | — | — | WO | claimed |
| WO-1998049191-A1 | NOVEL PULMONARY SURFACTANTS AND THERAPEUTIC USES, INCLUDING PULMONARY LAVAGE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-11-05 | — | — | WO | claimed |
| WO-1998043670-A2 | AQUEOUS IMMUNOLOGIC ADJUVANT COMPOSITIONS OF MONOPHOSPHORYL LIPID A | RIBI IMMUNOCHEM RESEARCH, INC. (US) | 1998-10-08 | — | — | WO | claimed |
| WO-1998033483-A1 | METHOD FOR UTILIZING NEUTRAL LIPIDS TO MODIFY IN VIVO RELEASE FROM MULTIVESICULAR LIPOSOMES | SKYEPHARMA, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| US-5789381-A | RESPIRATORY SYSTEM DISORDERS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-04 | — | — | US | claimed |
| US-5077036-A | Storage stability | ALLIANCE PHARMACEUTICAL CORP. (US) | 1991-12-31 | — | — | US | claimed |